Didier Dewailly

BackgroundFunctional hypothalamic amenorrhoea (FHA) is responsible for 20-35% of all cases of secondary amenorrhoea and, thus, is the second most common cause of secondary amenorrhoea after polycystic ovary syndrome (PCOS). A high number of…

Research questionClomiphene citrate (CC) is one of the first-line treatments for ovulation induction in women with anovulatory polycystic ovary syndrome (PCOS). However, nearly 1 out of 2 women is resistant to 50 mg/day of CC. The objective…

IntroductionThe management of posterior deep endometriosis is not consensual. This is due to a great heterogeneity of data from the literature. Many series were small and overall, predictors of pregnancy were not all included and analyzed b…

BackgroundPulsatile GnRH therapy is the gold standard treatment for ovulation induction in women having functional hypothalamic amenorrhea (FHA). The use of pulsatile GnRH therapy in FHA patients with polycystic ovarian morphology (PCOM), c…

ObjectiveDoes surgery for deep infiltrating endometriosis (DIE) before in vitro fertilization (IVF) improve pregnancy and birth rate?Patients and methodsCohort study of 177 consecutive patients with DIE related infertility and receiving IVF…

Les donnees de la litterature concourent a demontrer l’impact des desordres endocriniens et metaboliques du syndrome des ovaires micropolykystiques (SOMPK) sur la receptivite endometriale, contribuant a l’infertilite qui lui est associee. L…

Mimant de nombreuses pathologies, la grossesse extra-uterine ovarienne (GEU) est de diagnostic difficile, surtout apres hyperstimulation ovarienne controlee et ponction ovocytaire en vue de fecondation in vitro (FIV). Nous rapportons ici le…

Intrauterine insemination has been proposed for a long time and its place took benefits from the knowledge in IVF: sperm preparation and ovarian stimulation. Initially the first line therapy for male factor, cervical factor and unexplained …